Cancer treatment, as well as cancer itself, are common causes of lymphedema, a buildup of protein and fluid (lymph) in soft tissues that causes swelling, often in an arm or leg. This is because lymph ...
A person with Down syndrome may be more likely to develop obesity than someone without it. This is due to additional medical conditions and physiological factors, among other reasons. A person who ...
The flu shot and other vaccines (like those for COVID-19) are not only safe but beneficial if you have breast cancer, helping you avoid vaccine-preventable diseases. While many vaccines are safe for ...
Here's a look at the latest research and promising results: After trying to address diabetes and obesity, GLP-1 studies have focused on CV risks and events. The SELECT trial found semaglutide ...
GLP-1 receptor agonists are revolutionizing health care, moving beyond diabetes and obesity to treat cardiovascular, kidney, and possibly neurodegenerative diseases. As usage expands and costs drop, ...
Study finds bariatric surgery declined with rise in GLP-1 drugs to treat obesity Date: October 25, 2024 Source: Brigham and Women's Hospital Summary: A new study has examined a large sample of ...
GLP-1s are being tested on patients with Alzheimer’s, on top of conditions that can often go hand-in-hand with obesity. For pharmaceutical companies that are (or want to be) big players in areas ...
Lilly's Mounjaro to cost 2,200 Danish crowns per month Wegovy's price ranges from 1,313 to 2,353 crowns per month Denmark's public health system does not reimburse weight-loss drugs The two ...
New precision medicine approach helps detect subgroups of people with obesity at high risk of diabetes and heart disease Date: October 24, 2024 Source: Lund University Summary: Obesity is a common ...
The UK's drug safety regulator is asking doctors to be alert for patients who may be misusing obesity injections, such as Wegovy. It follows reports of some people who are not obese becoming sick ...